Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NKTR-181 in Opioid-Naïve Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee
NCT01619839Phase 2Completed
- Sponsor
- Nektar Therapeutics
- Start
- Jun 2012
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of loxicodegol in knee osteoarthritis (OA), sponsored by Nektar Therapeutics. Started Jun 2012; status: completed.
02
Drugs
loxicodegol
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01619839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01619839.